| Identification of Chalcones as Fasciola hepatica Cathepsin L Inhibitors Using a Comprehensive Experimental and Computational Approach F Ferraro, A Merlino, N dell´ Oca, J Gil, JF Tort, M Gonzalez, H Cerecetto, ... PLoS neglected tropical diseases 10 (7), e0004834, 2016 | 31 | 2016 |
| Novel and selective inactivators of Triosephosphate isomerase with anti-trematode activity F Ferraro, I Corvo, L Bergalli, A Ilarraz, M Cabrera, J Gil, BM Susuki, ... Scientific reports 10 (1), 2587, 2020 | 17 | 2020 |
| Substrate Specificity of Cysteine Proteases Beyond the S2 Pocket: Mutagenesis and Molecular Dynamics Investigation of Fasciola hepatica Cathepsins L I Corvo, F Ferraro, A Merlino, K Zuberbühler, AJ O'Donoghue, L Pastro, ... Frontiers in Molecular Biosciences 5, 40, 2018 | 15 | 2018 |
| Insight into the mechanism of action and selectivity of caspase-3 reversible inhibitors through in silico studies L Minini, F Ferraro, S Cancela, A Merlino Journal of Molecular Structure 1147, 558-568, 2017 | 11 | 2017 |
| Cathepsin L Inhibitors with Activity against the Liver Fluke Identified From a Focus Library of Quinoxaline 1,4-di-N-Oxide Derivatives F Ferraro, A Merlino, J Gil, H Cerecetto, I Corvo, M Cabrera Molecules 24 (13), 2348, 2019 | 10 | 2019 |
| In vitro and in vivo studies on a group of chalcones find promising results as potential drugs against fascioliasis Z Artía, F Ferraro, C Sánchez, H Cerecetto, J Gil, L Pareja, MN Alonzo, ... Experimental Parasitology 255, 108628, 2023 | 2 | 2023 |
| Flavonoid‐Quinoxaline Hybrid Compounds as Cathepsin Inhibitors Against Fascioliasis F Ferraro, A Merlino, J Gil, S Pérez‐Silanes, I Corvo, M Cabrera ChemMedChem 19 (18), e202400305, 2024 | 1 | 2024 |
| Novel Thermosensitive and Mucoadhesive Nasal Hydrogel Containing 5-MeO-DMT Optimized Using Box-Behnken Experimental Design P Miranda, A Castro, P Díaz, L Minini, F Ferraro, E Paulsen, R Faccio, ... Polymers 16 (15), 2148, 2024 | 1 | 2024 |
| Drug Targets: Screening for Small Molecules that Inhibit Fasciola hepatica Enzymes F Ferraro, MA Cabrera, GI Alvarez, I Corvo Fasciola hepatica: Methods and Protocols, 221-231, 2020 | 1 | 2020 |
| Caracterización bio-estructural de inhibidores de catepsinas de Fasciola hepatica como potenciales fármacos anihelmínticos F Ferraro Udelar. FQ, 2019 | 1 | 2019 |
| Obese children displayed deterioreted reverse cholesterol transport in association with insulin resistence, vascular inflammation and altered lipid metabolism M Martin, L Gaete, WF Tetzlaff, F Ferraro, EL Chiappe, EE Botta, V Osta, ... Atherosclerosis 315, e230, 2020 | | 2020 |
| Substrate Specificity of Cysteine Proteases Beyond the S2 Pocket: Mutagenesis and I Corvo, F Ferraro, A Merlino | | 2018 |
| Búsqueda de inhibidores de cisteína proteasas esenciales del parásito Fasciola hepatica como potenciales fármacos F Ferraro Udelar. FC., 2015 | | 2015 |
